PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations

Por Emmenegger, Urban, Ko, Yoo-Joung
Publicado em 2009

Coexistence of gastrointestinal stromal tumour and colorectal adenocarcinoma: Two case reports

Por Kumar, Kinshuk, Rowsell, Corwyn, Law, Calvin, Ko, Yoo-Joung
Publicado em 2011

A Bayesian Meta-Analysis of Multiple Treatment Comparisons of Systemic Regimens for Advanced Pancreatic Cancer

Por Chan, Kelvin, Shah, Keya, Lien, Kelly, Coyle, Doug, Lam, Henry, Ko, Yoo-Joung
Publicado em 2014

A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer

Por Deobald, Raymond G, Cheng, Eva S W, Ko, Yoo-Joung, Wright, Frances C, Karanicolas, Paul J
Publicado no HPB (Oxford) (2015)

Management of Metastatic Solid Pseudopapillary Cancer of the Pancreas: A Case Report

Por Dixon, Matthew, Cannon, John, Kagedan, Daniel, Rowsell, Corwyn, Milot, Laurent, Ko, Yoo-Joung, Coburn, Natalie
Publicado no World J Oncol (2013)

Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?

Por Hanna Sherif, Ko Yoo-Joung, Gladdy Rebecca, Rowsell Corwyn H, Khalifa Mahmoud A, Smith Andy, Law Calvin
Publicado em 2006-12-01

Is EGFR expression altered following postoperative chemotherapy for colorectal adenocarcinoma?

Por Khalifa, Mahmoud A, Rowsell, Corwyn H, Gladdy, Rebecca, Ko, Yoo-Joung, Hanna, Sherif, Smith, Andy, Law, Calvin
Publicado em 2006

A Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal Cancer

Por Kumachev, Alexander, Yan, Marie, Berry, Scott, Ko, Yoo-Joung, Martinez, Maria C. R., Shah, Keya, Chan, Kelvin K. W.
Publicado no PLoS One (2015)

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer

Por Emmenegger, Urban, Booth, Christopher M., Berry, Scott, Sridhar, Srikala S., Winquist, Eric, Bandali, Nesan, Chow, Annabelle, Lee, Christina, Xu, Ping, Man, Shan, Kerbel, Robert S., Ko, Yoo-Joung
Publicado no Oncologist (2015)

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, a...

Por Fung, Andrea S., Tam, Vincent C., Meyers, Daniel E., Sim, Hao‐Wen, Knox, Jennifer J., Zaborska, Valeriya, Davies, Janine, Ko, Yoo‐Joung, Batuyong, Eugene, Samawi, Haider, Cheung, Winson Y., Lee‐Ying, Richard
Publicado no Cancer Med (2020)

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

Por Alghamdi, Mohammed A., Amaro, Carla P., Lee‐Ying, Richard, Sim, Hao‐Wen, Samwi, Haider, Chan, Kelvin K., Knox, Jennifer J., Ko, Yoo‐Joung, Swiha, Mina, Batuyong, Eugene, Romagnino, Adriana, Cheung, Winson Y., Tam, Vincent C.
Publicado no Cancer Med (2020)

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

Por Samawi, Haider H., Sim, Hao‐Wen, Chan, Kelvin K., Alghamdi, Mohammad A., Lee‐Ying, Richard M., Knox, Jennifer J., Gill, Parneet, Romagnino, Adriana, Batuyong, Eugene, Ko, Yoo‐Joung, Davies, Janine M., Lim, Howard J., Cheung, Winson Y., Tam, Vincent C.
Publicado no Cancer Med (2018)

Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer

Por Taplin, Mary-Ellen, Regan, Meredith M., Ko, Yoo-Joung, Bubley, Glenn J., Duggan, Stephen E., Werner, Lillian, Beer, Tomasz M., Ryan, Christopher W., Mathew, Paul, Tu, Shi-Ming, Denmeade, Samuel R., Oh, William K., Sartor, Oliver, Mantzoros, Christos S., Rittmaster, Roger, Kantoff, Philip W., Balk, Steven P.
Publicado em 2009

Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therapy for Advanced Urothelial Carcinoma

Por Agarwal, Neeraj, Bellmunt, Joaquim, Maughan, Benjamin L., Boucher, Kenneth M., Choueiri, Toni K., Qu, Angela Q., Vogelzang, Nicholas J., Fougeray, Ronan, Niegisch, Guenter, Albers, Peter, Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srikala S., Tantravahi, Srinivas K., Galsky, Matthew D., Petrylak, Daniel P., Vaishampayan, Ulka N., Mehta, Amitkumar N., Beer, Tomasz M., Sternberg, Cora. N., Rosenberg, Jonathan E., Sonpavde, Guru
Publicado em 2013

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2...

Por Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K., Qu, Angela Q., Vaughn, David J., Niegisch, Guenter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srikala S., Galsky, Matthew D., Petrylak, Daniel P., Vaishampayan, Ulka N., Khan, Awais, Vogelzang, Nicholas J., Beer, Tomasz M., Stadler, Walter M., O’Donnell, Peter H., Sternberg, Cora N., Rosenberg, Jonathan E., Bellmunt, Joaquim
Publicado em 2012